Atara Biotherapeutics, Inc. - Common Stock (ATRA)
CUSIP: 046513107
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,165,808
- Total 13F shares
- 99,815,040
- Share change
- +1,968,494
- Total reported value
- $777,439,383
- Price per share
- $7.79
- Number of holders
- 132
- Value change
- +$14,024,584
- Number of buys
- 64
- Number of sells
- 63
Quarterly Holders Quick Answers
What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 046513107:
Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO |
13F
|
Company |
100%
|
8,189,899
|
$76,085,000 | — | 31 Mar 2022 | |
| BAUPOST GROUP LLC/MA |
13F
|
Company |
99%
|
8,123,616
|
$75,468,000 | — | 31 Mar 2022 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
96%
|
7,855,824
|
$72,981,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
96%
|
7,800,139
|
$72,461,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
85%
|
6,912,574
|
$64,217,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
77%
|
6,273,617
|
$58,282,000 | — | 31 Mar 2022 | |
| Redmile Group, LLC |
13F
|
Company |
76%
|
6,245,911
|
$58,025,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
70%
|
5,746,740
|
$53,387,000 | — | 31 Mar 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
50%
|
4,103,676
|
$38,123,000 | — | 31 Mar 2022 | |
| WASATCH ADVISORS LP |
13F
|
Company |
47%
|
3,823,588
|
$35,521,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
45%
|
3,638,106
|
$33,798,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
37%
|
3,039,514
|
$28,236,000 | — | 31 Mar 2022 | |
| KPCB XV Associates, LLC |
13F
|
Company |
23%
|
1,876,650
|
$17,434,000 | — | 31 Mar 2022 | |
| 683 Capital Management, LLC |
13F
|
Company |
22%
|
1,830,000
|
$17,001,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
21%
|
1,681,106
|
$15,617,000 | — | 31 Mar 2022 | |
| EMINENCE CAPITAL, LP |
13F
|
Company |
17%
|
1,367,710
|
$12,706,000 | — | 31 Mar 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
17%
|
1,356,451
|
$12,600,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
16%
|
1,340,251
|
$12,451,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
13%
|
1,065,170
|
$10,023,000 | — | 31 Mar 2022 | |
| Antipodean Advisors LLC |
13F
|
Company |
12%
|
1,000,000
|
$9,290,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
12%
|
1,000,000
|
$9,290,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
12%
|
975,858
|
$9,065,721 | — | 31 Mar 2022 | |
| CITIGROUP INC |
13F
|
Company |
11%
|
865,144
|
$8,037,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
10%
|
831,952
|
$7,730,000 | — | 31 Mar 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
8.9%
|
729,686
|
$6,779,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
8.1%
|
662,959
|
$6,159,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
7.9%
|
641,875
|
$5,964,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
7%
|
569,800
|
$5,293,000 | — | 31 Mar 2022 | |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC |
13F
|
Company |
6.4%
|
525,000
|
$4,877,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
5.5%
|
445,081
|
$4,135,000 | — | 31 Mar 2022 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
5.3%
|
429,766
|
$3,993,000 | — | 31 Mar 2022 | |
| M28 Capital Management LP |
13F
|
Company |
4.8%
|
389,353
|
$3,617,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
4.7%
|
387,085
|
$3,596,000 | — | 31 Mar 2022 | |
| Alberta Investment Management Corp |
13F
|
Company |
4.7%
|
382,930
|
$3,557,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
3.9%
|
315,267
|
$2,929,000 | — | 31 Mar 2022 | |
| One Fin Capital Management LP |
13F
|
Company |
3.7%
|
303,000
|
$2,815,000 | — | 31 Mar 2022 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
3.7%
|
300,000
|
$2,787,000 | — | 31 Mar 2022 | |
| STALEY CAPITAL ADVISERS INC |
13F
|
Company |
3.7%
|
300,000
|
$2,787,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
3.1%
|
249,283
|
$2,316,000 | — | 31 Mar 2022 | |
| SG Americas Securities, LLC |
13F
|
Company |
2.5%
|
206,374
|
$1,917,000 | — | 31 Mar 2022 | |
| NATIXIS |
13F
|
Company |
2.3%
|
187,800
|
$1,745,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.3%
|
186,377
|
$1,732,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
2.2%
|
177,700
|
$1,651,000 | — | 31 Mar 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2%
|
163,567
|
$1,519,000 | — | 31 Mar 2022 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
1.9%
|
156,559
|
$1,454,000 | — | 31 Mar 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
1.8%
|
150,401
|
$1,397,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
134,743
|
$1,252,000 | — | 31 Mar 2022 | |
| Gamma As Sector |
13F
|
Individual |
1.5%
|
123,713
|
$1,149,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
1.5%
|
119,354
|
$1,109,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.4%
|
117,264
|
$1,089,000 | — | 31 Mar 2022 |
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2022
As of 30 Jun 2022,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
99,815,040 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, BlackRock Inc., BAUPOST GROUP LLC/MA, MAVERICK CAPITAL LTD, VANGUARD GROUP INC, Redmile Group, LLC, STATE STREET CORP, FMR LLC, WASATCH ADVISORS INC, and Point72 Asset Management, L.P..
This page lists
132
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
139
Q2 2022 holders
132
Holder diff
-7
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.